Einstein, M. H., Takacs, P., Chatterjee, A., Sperling, R. S., Chakhtoura, N., Blatter, M. M., . . . Dubin, G. (2014). Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial. Hum Vaccin Immunother.
Dyfyniad Arddull ChicagoEinstein, Mark H., et al. "Comparison of Long-term Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine and HPV-6/11/16/18 Vaccine in Healthy Women Aged 18-45 years: End-of-study Analysis of a Phase III Randomized Trial." Hum Vaccin Immunother 2014.
Dyfyniad MLAEinstein, Mark H., et al. "Comparison of Long-term Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine and HPV-6/11/16/18 Vaccine in Healthy Women Aged 18-45 years: End-of-study Analysis of a Phase III Randomized Trial." Hum Vaccin Immunother 2014.